Organism name | Crocus sativus |
---|---|
Genus | Crocus |
Family | Iridaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Crocus sativus |
---|---|
Linked NCBI taxonomy ID | 82528 |
Linked level | species |
Family in NCBI taxonomy | Iridaceae |
---|---|
ID | 26339 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Liliopsida |
---|---|
ID | 4447 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005564
![]() |
Crosatoside A
/ Isorhamnetin 4'-neohesperidoside / Quercetin 3'-methyl ether 4'-rhamnosyl-(1->2)-glucoside |
No. 1 | No. 15 |
![]() |
||||
C00013740
![]() |
Kaempferol 7-sophoroside
/ 7-[(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)oxy]-3,5-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
No. 1 | No. 15 |
![]() |
||||
C00005149
![]() |
Populnin
/ Kaempferol 7-glucoside |
CHEMBL469441
CHEMBL1159471 |
No. 2 | No. 15 |
![]() |
|||
C00005138
![]() |
Astragalin
/ Kaempferol 3-glucoside / Kaempferol 3-O-beta-D-glucoside / Kaempferol 3-O-beta-D-glucopyranoside |
CHEMBL233930
CHEMBL453290 CHEMBL1572115 |
C001579
|
10 / 6 / 7 | 0 / 1 | No. 2 | No. 15 |
![]() |
C00000931
![]() |
Zeaxanthin
/ all-trans-Zeaxanthin |
CHEMBL1357855
CHEMBL2359248 |
C005881
|
4 / 2 / 3 | 1 / 0 | No. 26 | No. 59 |
![]() |
C00004565
![]() |
Kaempferol
/ Nimbecetin / Rhamnolutein / Pelargidenolon / 5,7,4'-Trihydroxyflavonol / 3,5,7,4'-Tetrahydroxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL150
|
C006552
|
76 / 69 / 87 | 86 / 8 | No. 71 | No. 15 |
![]() |
C00043821
![]() |
Picrocrocin
|
C087962
|
No. 316 |
![]() |
||||
C00002668
![]() |
Protocatechuic acid
/ 3,4-Dihydroxybenzoic acid |
CHEMBL37537
|
C009091
|
33 / 19 / 19 | 2 / 0 | No. 817 | No. 81 |
![]() |
C00000152
![]() |
p-Coumaric acid
|
CHEMBL66879
CHEMBL2336752 |
C032171
|
23 / 13 / 18 | 6 / 1 | No. 904 | No. 6 |
![]() |
C00007444
![]() |
Adenosine
|
CHEMBL477
CHEMBL11909 CHEMBL20247 CHEMBL1090 CHEMBL91573 CHEMBL145188 CHEMBL1236872 CHEMBL1413677 CHEMBL2051971 |
D000241
|
61 / 89 / 68 | 33 / 35 | No. 1060 |
![]() |
|
C00002682
![]() |
Vanillic acid
/ 3-Methoxy-4-hydroxybenzoic acid |
CHEMBL120568
|
D014641
|
5 / 3 / 3 | 5 / 0 | No. 1073 |
![]() |
|
C00029502
![]() |
3-Hydroxy-4-methoxybenzoic acid
|
CHEMBL88700
|
C045317
|
2 / 1 / 4 | No. 1073 |
![]() |
||
C00031089
![]() |
Protocatechuic acid methyl ester
|
CHEMBL486027
|
7 / 3 / 5 | No. 1722 |
![]() |
|||
C00001736
![]() |
Harman
/ Harmane / Indoter / Locuturin / Zygofabagine |
CHEMBL12014
|
C005010
|
109 / 46 / 33 | 2 / 2 | No. 1889 | No. 4 |
![]() |
C00003768
![]() |
Crocetin
|
CHEMBL464792
CHEMBL1993367 |
C010561
|
1 / 0 / 0 | 0 / 2 | No. 2031 |
![]() |
|
C00030771
![]() |
Methylparaben
/ p-Methoxycarbonylphenol |
CHEMBL325372
|
C015358
|
102 / 49 / 57 | 3 / 0 | No. 2169 |
![]() |
|
C00045563
![]() |
3-Hydroxy-beta-ionone
|
No. 2480 | No. 38 |
![]() |
||||
C00023155
![]() |
Crocetin glucosyl ester
/ 8,8'-Diapo-psi,psi-carotenedioic acid mono-beta-D-glucopyranosyl ester |
No. 3360 |
![]() |
|||||
C00045543
![]() |
2-Hydroxy-3,5,5-trimethylcyclohex-2-ene-1,4-dione
|
No. 3558 |
![]() |
|||||
C00001513
![]() |
Uracil
|
CHEMBL566
|
D014498
|
2 / 1 / 1 | 1 / 8 | No. 3873 |
![]() |
|
C00045803
![]() |
Crocin 2
/ Crocin 3 |
CHEMBL2311863
|
No. 4277 |
![]() |
||||
C00003769
![]() |
Crocin
/ alpha-crocin / Crocetin digentiobioside |
CHEMBL446785
|
C029036
|
3 / 0 / 0 | 0 / 2 | No. 4277 |
![]() |
|
C00043190
![]() |
3-Formyl-6-hydroxy-2,4,4-trimethyl-2,5-cyclohexadien-1-one
/ 4-Hydroxy-2,6,6-trimethyl-3-oxocyclohexa-1,4-diene-1-carboxaldehyde |
No. 4746 |
![]() |
|||||
C00043412
![]() |
Crocusatin I
|
No. 4746 |
![]() |
|||||
C00043413
![]() |
Crocusatin J
/ (+)-Crocusatin J |
CHEMBL451697
CHEMBL446756 |
No. 5112 |
![]() |
||||
C00043414
![]() |
Crocusatin K
/ (+)-Crocusatin K |
CHEMBL451697
CHEMBL446756 |
No. 5112 |
![]() |
||||
C00001756
![]() |
Perlolyrine
/ Tribulusterine |
CHEMBL501991
|
C055781
|
No. 5379 | No. 4 |
![]() |
||
C00043415
![]() |
Crocusatin L
/ (+)-Crocusatin L |
CHEMBL455866
|
No. 5442 |
![]() |
||||
C00043204
![]() |
4-Hydroxy-3,5,5-trimethylcyclohex-2-enone
|
No. 6168 |
![]() |
|||||
C00045805
![]() |
Crocusatin G
/ (+)-Crocusatin G |
No. 6675 |
![]() |
|||||
C00045806
![]() |
Crocusatin H
/ (+)-Crocusatin H |
CHEMBL451014
|
No. 7177 |
![]() |
||||
C00000209
![]() |
Vitamin B
/ Nicotinamide |
CHEMBL1140
|
D009536
|
96 / 36 / 31 | 24 / 28 | No. 8036 | No. 1 |
![]() |
C00045804
![]() |
Crocusatin F
/ (-)-Crocusatin F |
No. 8161 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q9UNA4 | DNA polymerase iota | Enzyme | C00001736 C00002668 C00002682 C00004565 C00005138 C00030771 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000152 C00000209 C00002668 C00002682 C00004565 C00030771 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000209 C00001736 C00004565 C00007444 C00030771 | 0 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000152 C00000209 C00002668 C00030771 C00031089 | 1 / 2 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000209 C00001736 C00004565 C00007444 C00030771 | 1 / 1 |
P15121 | Aldose reductase | Enzyme | C00000152 C00002668 C00002682 C00004565 C00005138 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00000209 C00000931 C00001513 C00002668 C00007444 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000209 C00001736 C00004565 C00007444 C00030771 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000152 C00000209 C00004565 C00029502 C00030771 | 0 / 3 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000152 C00000209 C00004565 C00007444 C00030771 | 1 / 8 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000209 C00001736 C00004565 C00007444 C00030771 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000209 C00001736 C00004565 C00007444 C00030771 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000209 C00001736 C00004565 C00030771 | 1 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000209 C00003768 C00004565 C00030771 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001736 C00004565 C00005138 C00007444 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001736 C00002668 C00004565 C00007444 | 4 / 3 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000152 C00002668 C00030771 C00031089 | 0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000152 C00002668 C00030771 C00031089 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000209 C00004565 C00007444 C00030771 | 2 / 2 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000152 C00002668 C00030771 C00031089 | 0 / 1 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000152 C00002668 C00030771 C00031089 | 1 / 2 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000152 C00002668 C00030771 C00031089 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000209 C00001736 C00007444 C00030771 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000209 C00007444 C00030771 | 5 / 9 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000209 C00001736 C00030771 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000209 C00007444 C00030771 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00000152 C00004565 C00005138 | 4 / 2 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000209 C00007444 C00030771 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000209 C00004565 C00030771 | 0 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000931 C00003769 C00004565 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001736 C00005138 C00007444 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000209 C00002668 C00030771 | 0 / 1 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001736 C00002668 C00004565 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000931 C00003769 C00007444 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000209 C00007444 C00030771 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000209 C00007444 C00030771 | 0 / 1 |
P17252 | Protein kinase C alpha type | Alpha | C00000209 C00001736 C00030771 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000209 C00001736 C00030771 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00001736 C00004565 C00007444 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001736 C00004565 C00007444 | 1 / 2 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000209 C00002668 C00030771 | 2 / 2 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000209 C00007444 C00030771 | 1 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00004565 C00030771 C00031089 | 1 / 1 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000209 C00007444 C00030771 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000209 C00030771 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00004565 C00007444 | 11 / 10 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000209 C00030771 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000209 C00030771 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000209 C00030771 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00001736 C00007444 | 3 / 2 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000209 C00030771 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000209 C00030771 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000209 C00030771 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00001736 C00007444 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000209 C00030771 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000209 C00030771 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000209 C00030771 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000209 C00030771 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000209 C00030771 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000209 C00030771 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000209 C00030771 | 0 / 0 |
P51580 | Thiopurine S-methyltransferase | Enzyme | C00002682 C00029502 | 1 / 1 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000209 C00030771 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000209 C00030771 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001736 C00004565 | 2 / 2 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001736 C00004565 | 3 / 3 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00001736 C00004565 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00004565 C00030771 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000209 C00030771 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000209 C00030771 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000209 C00030771 | 2 / 1 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000209 C00030771 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000209 C00030771 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000209 C00030771 | 1 / 1 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000152 C00002668 | 3 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00001736 C00004565 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000209 C00030771 | 1 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000209 C00030771 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000209 C00030771 | 3 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000209 C00030771 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000209 C00030771 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000209 C00030771 | 1 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000209 C00030771 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000209 C00030771 | 2 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000209 C00030771 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00000209 C00030771 | 2 / 1 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000209 C00030771 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000209 C00030771 | 2 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000209 C00030771 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002668 C00004565 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000209 C00030771 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000209 C00030771 | 2 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001736 C00007444 | 2 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000209 C00030771 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000209 C00030771 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00004565 C00005138 | 1 / 1 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000209 C00030771 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00004565 C00005138 | 1 / 1 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000152 C00002668 | 0 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000209 C00030771 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000209 C00030771 | 1 / 1 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000209 C00030771 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000209 C00030771 | 1 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00004565 C00007444 | 0 / 1 |
P08311 | Cathepsin G | S1A | C00000209 C00030771 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000209 C00030771 | 1 / 1 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000209 C00030771 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00001736 C00004565 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000209 C00030771 | 0 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001736 C00004565 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000209 C00030771 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000209 C00030771 | 1 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000209 C00030771 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001736 C00004565 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000209 C00030771 | 1 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000152 C00002668 | 1 / 1 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000209 C00030771 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000209 C00030771 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000209 C00030771 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00004565 C00030771 | 7 / 37 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002668 C00030771 | 0 / 0 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000209 C00030771 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000209 C00030771 | 0 / 1 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000209 C00030771 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000209 C00030771 | 1 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000209 C00030771 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000209 C00030771 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000209 C00030771 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00004565 C00007444 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000209 C00030771 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00002682 C00007444 | 1 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00004565 C00007444 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00030771 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000209 | 0 / 0 |
O96013 | Serine/threonine-protein kinase PAK 4 | STE serine/threonine protein kinase PAKB subfamily | C00001736 | 0 / 0 |
O43781 | Dual specificity tyrosine-phosphorylation-regulated kinase 3 | CMGC dual-specificity kinase DYRK2 | C00001736 | 0 / 0 |
Q92630 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | CMGC dual-specificity kinase DYRK2 | C00001736 | 0 / 0 |
Q96SB4 | SRSF protein kinase 1 | Srpk | C00001736 | 0 / 0 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000152 | 0 / 0 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000152 | 0 / 0 |
Q8IXJ6 | NAD-dependent protein deacetylase sirtuin-2 | Enzyme | C00000209 | 0 / 0 |
Q9P286 | Serine/threonine-protein kinase PAK 7 | STE serine/threonine protein kinase PAKB subfamily | C00001736 | 0 / 0 |
Q8N5S9 | Calcium/calmodulin-dependent protein kinase kinase 1 | META serine/threonine protein kinase subfamily | C00001736 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00004565 | 1 / 1 |
P16581 | E-selectin | Adhesion | C00002668 | 0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00001736 | 0 / 0 |
Q16513 | Serine/threonine-protein kinase N2 | Pkn | C00001736 | 0 / 0 |
O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | C00001736 | 0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00004565 | 0 / 0 |
P07711 | Cathepsin L1 | C1A | C00002668 | 0 / 0 |
Q15418 | Ribosomal protein S6 kinase alpha-1 | Rskb | C00001736 | 0 / 0 |
O15264 | Mitogen-activated protein kinase 13 | p38 | C00001736 | 0 / 0 |
O75582 | Ribosomal protein S6 kinase alpha-5 | CAMK serine/threonine protein kinase MSKB subfamily | C00001736 | 0 / 0 |
P31751 | RAC-beta serine/threonine-protein kinase | Akt | C00001736 | 2 / 2 |
P53779 | Mitogen-activated protein kinase 10 | Jnk | C00001736 | 0 / 1 |
P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | C00000209 | 0 / 0 |
Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00004565 | 1 / 1 |
Q13188 | Serine/threonine-protein kinase 3 | STE serine/threonine protein kinase MST subfamily | C00001736 | 0 / 0 |
P51955 | Serine/threonine-protein kinase Nek2 | Nek | C00001736 | 0 / 0 |
Q96RR4 | Calcium/calmodulin-dependent protein kinase kinase 2 | META serine/threonine protein kinase subfamily | C00001736 | 0 / 0 |
Q15746 | Myosin light chain kinase, smooth muscle | Mlck | C00001736 | 1 / 1 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00007444 | 7 / 3 |
Q9BUB5 | MAP kinase-interacting serine/threonine-protein kinase 1 | CAMK serine/threonine protein kinase MNK subfamily | C00001736 | 0 / 0 |
P47901 | Vasopressin V1b receptor | Vasopressin and oxytocin receptor | C00007444 | 0 / 0 |
P42226 | Signal transducer and activator of transcription 6 | Unclassified protein | C00007444 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00002668 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000931 | 2 / 3 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00004565 | 0 / 0 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | C00007444 | 5 / 4 |
Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00004565 | 0 / 0 |
Q9HBX9 | Relaxin receptor 1 | Relaxin receptor | C00007444 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00001736 | 1 / 2 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00002668 | 1 / 1 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005138 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00004565 | 5 / 3 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00004565 | 0 / 0 |
P09619 | Platelet-derived growth factor receptor beta | Pdgfr | C00007444 | 5 / 1 |
Q14680 | Maternal embryonic leucine zipper kinase | Melk | C00001736 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00004565 | 4 / 4 |
Q9H422 | Homeodomain-interacting protein kinase 3 | CMGC dual-specificity kinase HIPK | C00001736 | 0 / 0 |
P55263 | Adenosine kinase | Enzyme | C00007444 | 1 / 0 |
P48730 | Casein kinase I isoform delta | Ck1 | C00001736 | 1 / 0 |
P06276 | Cholinesterase | Hydrolase | C00004565 | 0 / 0 |
Q16644 | MAP kinase-activated protein kinase 3 | CAMK serine/threonine protein kinase MAPKAPK | C00001736 | 0 / 0 |
Q9NQU5 | Serine/threonine-protein kinase PAK 6 | STE serine/threonine protein kinase PAKB subfamily | C00001736 | 0 / 0 |
Q9HBH9 | MAP kinase-interacting serine/threonine-protein kinase 2 | CAMK serine/threonine protein kinase MNK subfamily | C00001736 | 0 / 0 |
P04745 | Alpha-amylase 1 | Enzyme | C00004565 | 0 / 0 |
Q96GD4 | Aurora kinase B | Aur | C00001736 | 0 / 0 |
P49137 | MAP kinase-activated protein kinase 2 | CAMK serine/threonine protein kinase MAPKAPK | C00001736 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00004565 | 0 / 0 |
Q9UQB9 | Aurora kinase C | Aur | C00001736 | 1 / 1 |
P23443 | Ribosomal protein S6 kinase beta-1 | p70 | C00001736 | 0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00001736 | 0 / 0 |
P45983 | Mitogen-activated protein kinase 8 | Jnk | C00001736 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00004565 | 1 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00004565 | 0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00002668 | 1 / 3 |
Q9NTG7 | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Enzyme | C00000209 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00002668 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004565 | 2 / 0 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000152 | 0 / 0 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00004565 | 1 / 0 |
Q8WXD0 | Relaxin receptor 2 | Relaxin receptor | C00007444 | 1 / 1 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00004565 | 0 / 0 |
Q05513 | Protein kinase C zeta type | Iota | C00001736 | 0 / 0 |
P04183 | Thymidine kinase, cytosolic | Enzyme | C00007444 | 0 / 1 |
P29275 | Adenosine receptor A2b | Adenosine receptor | C00007444 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00004565 | 0 / 0 |
P12268 | Inosine-5'-monophosphate dehydrogenase 2 | Oxidoreductase | C00007444 | 0 / 0 |
P00813 | Adenosine deaminase | Hydrolase | C00007444 | 1 / 1 |
Q8TD43 | Transient receptor potential cation channel subfamily M member 4 | Unclassified protein | C00007444 | 1 / 1 |
P27448 | MAP/microtubule affinity-regulating kinase 3 | CAMK serine/threonine protein kinase MARK subfamily | C00001736 | 0 / 0 |
Q8IWQ3 | Serine/threonine-protein kinase BRSK2 | CAMK serine/threonine protein kinase BRSK subfamily | C00001736 | 0 / 0 |
O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | C00001736 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00005138 | 0 / 0 |
P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | C00001736 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00004565 | 0 / 0 |
Q8IW41 | MAP kinase-activated protein kinase 5 | CAMK serine/threonine protein kinase MAPKAPK | C00001736 | 0 / 0 |
O75116 | Rho-associated protein kinase 2 | Rock | C00001736 | 0 / 0 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00007444 | 0 / 0 |
P05771 | Protein kinase C beta type | Alpha | C00007444 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00004565 | 0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | C00001736 | 4 / 1 |
P45984 | Mitogen-activated protein kinase 9 | Jnk | C00001736 | 0 / 0 |
O00141 | Serine/threonine-protein kinase Sgk1 | AGC serine/threonine protein kinase SGK subfamily | C00001736 | 0 / 0 |
P14151 | L-selectin | Adhesion | C00002668 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00002668 | 1 / 0 |
P51812 | Ribosomal protein S6 kinase alpha-3 | Rskb | C00001736 | 2 / 2 |
P22894 | Neutrophil collagenase | M10A | C00002668 | 0 / 0 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00004565 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000152 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000152 | 0 / 0 |
P98170 | E3 ubiquitin-protein ligase XIAP | Other cytosolic protein | C00004565 | 1 / 1 |
Q9HC98 | Serine/threonine-protein kinase Nek6 | Nek | C00001736 | 0 / 0 |
Q96EB6 | NAD-dependent protein deacetylase sirtuin-1 | Enzyme | C00000209 | 0 / 0 |
Q9H2X6 | Homeodomain-interacting protein kinase 2 | CMGC dual-specificity kinase HIPK | C00001736 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002668 | 1 / 1 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00001736 | 1 / 0 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000152 | 1 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00004565 | 0 / 0 |
P41240 | Tyrosine-protein kinase CSK | Csk | C00001736 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00030771 | 5 / 1 |
P04062 | Glucosylceramidase | Enzyme | C00004565 | 6 / 4 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00030771 | 0 / 0 |
Q6DHV7 | Adenosine deaminase-like protein | Enzyme | C00007444 | 0 / 0 |
O15530 | 3-phosphoinositide-dependent protein kinase 1 | Pdk1 | C00001736 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00004565 | 3 / 4 |
P06746 | DNA polymerase beta | Enzyme | C00002668 | 0 / 0 |
Q15759 | Mitogen-activated protein kinase 11 | p38 | C00001736 | 0 / 0 |
P20839 | Inosine-5'-monophosphate dehydrogenase 1 | Oxidoreductase | C00007444 | 2 / 2 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00004565 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00000152 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00007444 | 4 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000152 | 0 / 0 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | C00004565 | 0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00004565 | 0 / 0 |
O96017 | Serine/threonine-protein kinase Chk2 | Rad53 | C00001736 | 4 / 1 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00004565 | 0 / 0 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000152 | 1 / 0 |
Q14012 | Calcium/calmodulin-dependent protein kinase type 1 | Camk1 | C00001736 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00002668 | 1 / 0 |
P48147 | Prolyl endopeptidase | S9A | C00004565 | 0 / 0 |
P17612 | cAMP-dependent protein kinase catalytic subunit alpha | Pka | C00001736 | 0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | C00001736 | 1 / 0 |
Q8TDX7 | Serine/threonine-protein kinase Nek7 | Nek | C00001736 | 0 / 0 |
P53778 | Mitogen-activated protein kinase 12 | p38 | C00001736 | 0 / 0 |
O00418 | Eukaryotic elongation factor 2 kinase | Atypical serine/threonine protein kinase alpha subfamily | C00001736 | 0 / 0 |
Q9GZV3 | High affinity choline transporter 1 | Choline Na-symporter | C00007444 | 1 / 0 |
Q8TD08 | Mitogen-activated protein kinase 15 | Mapk | C00001736 | 0 / 0 |
Q86V86 | Serine/threonine-protein kinase pim-3 | Pim | C00001736 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00003769 | 0 / 0 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00001736 | 0 / 0 |
P23526 | Adenosylhomocysteinase | Enzyme | C00007444 | 1 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00004565 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00007444 | 1 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00004565 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00004565 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002668 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002668 | 1 / 4 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001736 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001736 | 1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001736 | 1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001736 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001736 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001736 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001736 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001736 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001736 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001736 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001736 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001736 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001736 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001736 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001736 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001736 | 1 / 0 |
P11362 | Fibroblast growth factor receptor 1 | Fgfr | C00007444 | 4 / 5 |
P22455 | Fibroblast growth factor receptor 4 | Fgfr | C00007444 | 0 / 0 |
P22607 | Fibroblast growth factor receptor 3 | Fgfr | C00007444 | 14 / 6 |
P21802 | Fibroblast growth factor receptor 2 | TK tyrosine-protein kinase TLK subfamily | C00007444 | 9 / 3 |
P07205 | Phosphoglycerate kinase 2 | Enzyme | C00007444 | 0 / 0 |
P00558 | Phosphoglycerate kinase 1 | Enzyme | C00007444 | 1 / 1 |
Q9UBF8 | Phosphatidylinositol 4-kinase beta | Enzyme | C00007444 | 0 / 0 |
Q8TCG2 | Phosphatidylinositol 4-kinase type 2-beta | Enzyme | C00007444 | 0 / 0 |
Q9BTU6 | Phosphatidylinositol 4-kinase type 2-alpha | Enzyme | C00007444 | 0 / 0 |
P42356 | Phosphatidylinositol 4-kinase alpha | Enzyme | C00007444 | 0 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00004565 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00004565 | 0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00004565 | 0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00004565 | 0 / 0 |
P20248 | Cyclin-A2 | Other cytosolic protein | C00001736 | 0 / 0 |
P78396 | Cyclin-A1 | Other cytosolic protein | C00001736 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00004565 | 0 / 0 |
P68400 | Casein kinase II subunit alpha | Ck2 | C00001736 | 0 / 0 |
P19784 | Casein kinase II subunit alpha' | Ck2 | C00001736 | 0 / 0 |
P67870 | Casein kinase II subunit beta | REG serine/threonine protein kinase family | C00001736 | 0 / 0 |
Q92698 | DNA repair and recombination protein RAD54-like | Enzyme | C00001736 | 0 / 0 |
Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | C00001736 | 1 / 1 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00005138 | 0 / 3 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00004565 | 0 / 0 |
Q9NXA8 | NAD-dependent protein deacylase sirtuin-5, mitochondrial | Enzyme | C00000209 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001513 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000152
C00001736
C00004565
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00000209
C00004565
C00007444
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000209
C00004565
C00007444
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000209
C00004565
C00007444
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000209
C00001513
C00004565
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00004565
C00007444
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002682
C00004565
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002682
C00004565
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002682
C00004565
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00000152
C00002682
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000931
C00004565
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00004565
C00030771
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002682
C00004565
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00004565
C00007444
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00004565
C00007444
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000152
C00004565
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00001736
C00004565
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00004565
C00007444
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000209
C00004565
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00004565
C00007444
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00004565
C00007444
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00000209
C00004565
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000209
C00004565
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00004565
C00030771
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000152
C00004565
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00007444
|
37618 |
C00004565
|
||
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00004565
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00004565
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00004565
|
1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00004565
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00004565
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00004565
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00004565
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00004565
|
4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00004565
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00004565
|
9687 | GREB1 | growth regulation by estrogen in breast cancer 1 |
C00004565
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00004565
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00004565
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00004565
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00004565
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00004565
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00004565
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00004565
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00004565
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00004565
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00004565
|
4297 | KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TET1-MLL, TRX1, WDSTS | lysine (K)-specific methyltransferase 2A (EC:2.1.1.43) |
C00004565
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00004565
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00004565
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00004565
|
110357 |
C00004565
|
||
4502 | MT2A, MT2 | metallothionein 2A |
C00004565
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00004565
|
8202 | NCOA3, ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | nuclear receptor coactivator 3 (EC:2.3.1.48) |
C00004565
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00004565
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00004565
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00004565
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00004565
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00004565
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00004565
|
891 | CCNB1, CCNB | cyclin B1 |
C00004565
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00004565
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00004565
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00004565
|
2810 | SFN, YWHAS | stratifin |
C00004565
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00004565
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00004565
|
7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00004565
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00004565
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00004565
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00004565
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00004565
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00004565
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00004565
|
7161 | TP73, P73 | tumor protein p73 |
C00004565
|
7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00004565
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00004565
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00004565
|
239 | ALOX12, 12-LOX, 12S-LOX, LOG12 | arachidonate 12-lipoxygenase (EC:1.13.11.31) |
C00004565
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00004565
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00004565
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00004565
|
7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00004565
|
8839 | WISP2, CCN5, CT58, CTGF-L | WNT1 inducible signaling pathway protein 2 |
C00004565
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00002668
|
2023 | ENO1, ENO1L1, MPB1, NNE, PPH | enolase 1, (alpha) (EC:4.2.1.11) |
C00002668
|
3952 | LEP, LEPD, OB, OBS | leptin |
C00030771
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00004565
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000152
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00000152
|
100 | ADA | adenosine deaminase (EC:3.5.4.4) |
C00007444
|
134 | ADORA1, RDC7 | adenosine A1 receptor |
C00007444
|
135 | ADORA2A, A2aR, ADORA2, RDC8 | adenosine A2a receptor |
C00007444
|
140 | ADORA3, A3AR, AD026, bA552M11.5 | adenosine A3 receptor |
C00007444
|
248 | ALPI, IAP | alkaline phosphatase, intestinal (EC:3.1.3.1) |
C00007444
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00007444
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00007444
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00004565
|
929 | CD14 | CD14 molecule |
C00007444
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00007444
|
56616 | DIABLO, DFNA64, SMAC | diablo, IAP-binding mitochondrial protein |
C00007444
|
1803 | DPP4, ADABP, ADCP2, CD26, DPPIV, TP103 | dipeptidyl-peptidase 4 (EC:3.4.14.5) |
C00007444
|
8772 | FADD, MORT1 | Fas (TNFRSF6)-associated via death domain |
C00007444
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00007444
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00007444
|
23643 | LY96, ESOP-1, MD-2, MD2, ly-96 | lymphocyte antigen 96 |
C00007444
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00007444
|
9154 | SLC28A1, CNT1, HCNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 1 |
C00007444
|
9153 | SLC28A2, CNT2, HCNT2, HsT17153, SPNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 2 |
C00007444
|
2030 | SLC29A1, ENT1 | solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
C00007444
|
3177 | SLC29A2, DER12, ENT2, HNP36 | solute carrier family 29 (equilibrative nucleoside transporter), member 2 |
C00007444
|
55315 | SLC29A3, ENT3, HCLAP, HJCD, PHID | solute carrier family 29 (equilibrative nucleoside transporter), member 3 |
C00007444
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00007444
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00007444
|
31 | ACACA, ACAC, ACACAD, ACC, ACC1, ACCA | acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14) |
C00000209
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000209
|
6364 | CCL20, CKb4, LARC, MIP-3-alpha, MIP-3a, MIP3A, SCYA20, ST38 | chemokine (C-C motif) ligand 20 |
C00000209
|
1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00000209
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00000209
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000209
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00000209
|
389692 | MAFA, RIPE3b1, hMafA | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A |
C00000209
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00000209
|
2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00000209
|
4967 | OGDH, AKGDH, E1k, OGDC | oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) (EC:1.2.4.2) |
C00000209
|
5562 | PRKAA1, AMPK, AMPKa1 | protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) |
C00000209
|
5563 | PRKAA2, AMPK, AMPK2, AMPKa2, PRKAA | protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) |
C00000209
|
6194 | RPS6, S6 | ribosomal protein S6 |
C00000209
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00000209
|
22933 | SIRT2, SIR2, SIR2L, SIR2L2 | sirtuin 2 (EC:3.5.1.-) |
C00000209
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00000209
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#100800 | Achondroplasia; ach |
P22607
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#615224 | Advanced sleep phase syndrome, familial, 2; fasps2 |
P48730
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 P47869 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#207410 | Antley-bixler syndrome without genital anomalies or disordered steroidogenesis; abs2 |
P21802
|
#613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
#101200 | Apert syndrome |
P21802
|
#600807 | Asthma, susceptibility to |
Q13093
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#615007 | Basal ganglia calcification, idiopathic, 4; ibgc4 |
P09619
|
#123790 | Beare-stevenson cutis gyrata syndrome; bstvs |
P21802
|
#614592 | Bent bone dysplasia syndrome; bbds |
P21802
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#109800 | Bladder cancer |
P22607
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
O96017
P31749 |
#300615 | Brunner syndrome |
P21397
|
#610474 | Camptodactyly, tall stature, and hearing loss syndrome |
P22607
|
#615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#603956 | Cervical cancer |
P22607
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#303600 | Coffin-lowry syndrome; cls |
P51812
|
#114500 | Colorectal cancer; crc |
P31749
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#218800 | Crigler-najjar syndrome, type i |
P22309
|
#606785 | Crigler-najjar syndrome, type ii |
P22309
|
#123500 | Crouzon syndrome |
P21802
|
#612247 | Crouzon syndrome with acanthosis nigricans; can |
P22607
|
#219050 | Cryptorchidism, unilateral or bilateral |
Q8WXD0
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
P31751 |
#119900 | Digital clubbing, isolated congenital |
P15428
|
#246200 | Donohue syndrome |
P06213
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#614300 | Hypermethioninemia due to adenosine kinase deficiency |
P55263
|
#613752 | Hypermethioninemia with s-adenosylhomocysteine hydrolase deficiency |
P23526
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146000 | Hypochondroplasia; hch |
P22607
|
#147950 | Hypogonadotropic hypogonadism 2 with or without anosmia; hh2 |
P11362
|
#240900 | Hypoinsulinemic hypoglycemia with hemihypertrophy; hihghh |
P31751
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#123150 | Jackson-weiss syndrome; jws |
P21802
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
P09619
|
#182000 | Keratosis, seborrheic |
P22607
|
#149730 | Lacrimoauriculodentodigital syndrome; ladd |
P21802
P22607 |
#613837 | Leber congenital amaurosis 11; lca11 |
P20839
|
#601626 | Leukemia, acute myeloid; aml |
P09619
P36888 |
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#609265 | Li-fraumeni syndrome 2; lfs2 |
O96017
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#300635 | Lymphoproliferative syndrome, x-linked, 2; xlp2 |
P98170
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300844 | Mental retardation, x-linked 19; mrx19 |
P51812
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#602849 | Muenke syndrome; mnkes |
P22607
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#254500 | Myeloma, multiple |
P22607
|
#131440 | Myeloproliferative disorder, chronic, with eosinophilia |
P09619
|
#159900 | Myoclonic dystonia |
P14416
|
#228550 | Myofibromatosis, infantile, 1; imf1 |
P09619
|
#158580 | Neuronopathy, distal hereditary motor, type viia; hmn7a |
Q9GZV3
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#162900 | Nevus, epidermal |
P22607
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259500 | Osteogenic sarcoma |
O96017
|
#166250 | Osteoglophonic dysplasia; ogd |
P11362
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#604229 | Peters anomaly |
Q16678
|
#101600 | Pfeiffer syndrome |
P11362
P21802 |
#300653 | Phosphoglycerate kinase 1 deficiency |
P00558
|
#172700 | Pick disease of brain |
P10636
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#604559 | Progressive familial heart block, type ib; pfhb1b |
Q8TD43
|
#176807 | Prostate cancer |
O96017
|
#176920 | Proteus syndrome |
P31749
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#180105 | Retinitis pigmentosa 10; rp10 |
P20839
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#609579 | Scaphocephaly, maxillary retrusion, and mental retardation |
P21802
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#102700 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency |
P00813
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#243060 | Spermatogenic failure 5; spgf5 |
Q9UQB9
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601367 | Stroke, ischemic |
P16109
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#273300 | Testicular germ cell tumor; tgct |
P22607
|
#187600 | Thanatophoric dysplasia, type i; td1 |
P22607
|
#187601 | Thanatophoric dysplasia, type ii; td2 |
P22607
|
#610460 | Thiopurine s-methyltransferase deficiency |
P51580
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#190440 | Trigonocephaly 1; trigno1 |
P11362
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00881 | Li-Fraumeni syndrome |
O96017
(related)
P04637 (related) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P21802 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) P22607 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P09619 (related) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00664 | Anemia due to disorders of glycolytic enzymes |
P00558
(related)
|
H00092 | T-B-Severe combined immunodeficiencies (SCIDs) |
P00813
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
P16473 (related) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P31751 (related) P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04183
(marker)
P04637 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) P31751 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
P22607 (related) |
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P27487 (marker) P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
Q8WXD0 (related) |
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00255 | Hypogonadotropic hypogonadism |
P11362
(related)
|
H00443 | Osteoglophonic dysplasia (OD) |
P11362
(related)
|
H00458 | Craniosynostosis |
P11362
(related)
P21802 (related) P22607 (related) |
H00516 | Isolated orofacial clefts |
P11362
(related)
|
H01207 | Trigonocephaly |
P11362
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P20839
(related)
P22748 (related) |
H00837 | Leber congenital amaurosis (LCR) |
P20839
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00642 | Lacrimo-auriculo-dento-digital syndrome (LADD) |
P21802
(related)
P22607 (related) |
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00505 | FGFR3-related short limb skeletal dysplasias |
P22607
(related)
|
H00997 | CATSHL syndrome |
P22607
(related)
|
H00184 | Hypermethioninemia |
P23526
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
P51812 (related) Q99714 (related) |
H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) |
P51580
(related)
|
H00574 | Coffin-Lowry syndrome (CLS) |
P51812
(related)
|
H00606 | Early infantile epileptic encephalopathy |
P53779
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P98170
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00523 | Noonan syndrome and related disorders |
Q02750
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H01263 | Progressive cardiac conduction defect (PCCD) |
Q8TD43
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H01282 | Spermatogenic failure |
Q9UQB9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D012640 | Seizures |
C00001736
C00007444 C00000209 |
D009410 | Nerve Degeneration |
C00007444
C00000209 |
D014202 | Tremor |
C00001736
C00007444 |
D050197 | Atherosclerosis |
C00004565
C00003769 |
D007680 | Kidney Neoplasms |
C00000209
C00001513 |
D009202 | Cardiomyopathies |
C00004565
C00007444 |
D006973 | Hypertension |
C00007444
C00000209 |
D006943 | Hyperglycemia |
C00004565
C00000209 |
D002545 | Brain Ischemia |
C00007444
C00000209 |
D006948 | Hyperkinesis |
C00000209
|
D011297 | Prenatal Exposure Delayed Effects |
C00004565
|
D055371 | Acute Lung Injury |
C00003768
|
D007333 | Insulin Resistance |
C00003768
|
D003072 | Cognition Disorders |
C00003769
|
D008545 | Melanoma |
C00000152
|
D001145 | Arrhythmias, Cardiac |
C00007444
|
D001249 | Asthma |
C00007444
|
D001282 | Atrial Flutter |
C00007444
|
D054537 | Atrioventricular Block |
C00007444
|
D001321 | Autistic Disorder |
C00007444
|
D001919 | Bradycardia |
C00007444
|
D007938 | Leukemia |
C00004565
|
D001986 | Bronchial Spasm |
C00007444
|
D002389 | Catatonia |
C00007444
|
D002637 | Chest Pain |
C00007444
|
D004244 | Dizziness |
C00007444
|
D004827 | Epilepsy |
C00007444
|
D004830 | Epilepsy, Tonic-Clonic |
C00007444
|
D005119 | Extravasation of Diagnostic and Therapeutic Materials |
C00007444
|
D006333 | Heart Failure |
C00007444
|
D006930 | Hyperalgesia |
C00007444
|
D006940 | Hyperemia |
C00007444
|
D002318 | Cardiovascular Diseases |
C00004565
|
D006977 | Hypertension, Renal |
C00007444
|
D007022 | Hypotension |
C00007444
|
D007174 | Impulse Control Disorders |
C00007444
|
D008106 | Liver Cirrhosis, Experimental |
C00007444
|
D017202 | Myocardial Ischemia |
C00007444
|
D009336 | Necrosis |
C00007444
|
D001943 | Breast Neoplasms |
C00004565
|
D009422 | Nervous System Diseases |
C00007444
|
D010146 | Pain |
C00007444
|
D054138 | Sinus Arrest, Cardiac |
C00007444
|
D013610 | Tachycardia |
C00007444
|
D013617 | Tachycardia, Supraventricular |
C00007444
|
D017180 | Tachycardia, Ventricular |
C00007444
|
D014693 | Ventricular Fibrillation |
C00007444
|
D007516 | Adenoma, Islet Cell |
C00000209
|
D020520 | Brain Infarction |
C00000209
|
D002653 | Child Behavior Disorders |
C00000209
|
D002972 | Cleft Palate |
C00000209
|
D003921 | Diabetes Mellitus, Experimental |
C00000209
|
D003924 | Diabetes Mellitus, Type 2 |
C00000209
|
D056486 | Drug-Induced Liver Injury |
C00000209
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00000209
|
D006330 | Heart Defects, Congenital |
C00000209
|
D006937 | Hypercholesterolemia |
C00000209
|
D010024 | Osteoporosis |
C00004565
|
D006951 | Hyperlipoproteinemias |
C00000209
|
D015228 | Hypertriglyceridemia |
C00000209
|
D052456 | Hypoalphalipoproteinemias |
C00000209
|
D007674 | Kidney Diseases |
C00000209
|
D003876 | Dermatitis, Atopic |
C00005138
|
D017880 | Limb Deformities, Congenital |
C00000209
|
D019636 | Neurodegenerative Diseases |
C00000209
|
D010190 | Pancreatic Neoplasms |
C00000209
|
D010391 | Pemphigoid, Bullous |
C00000209
|
D012393 | Rosacea |
C00000209
|
D020521 | Stroke |
C00000209
|
D014657 | Vasculitis |
C00000209
|
D006965 | Hyperplasia |
C00001513
|
D009362 | Neoplasm Metastasis |
C00001513
|
D020163 | Ornithine Carbamoyltransferase Deficiency Disease |
C00001513
|
D010212 | Papilloma |
C00001513
|
D011230 | Precancerous Conditions |
C00001513
|
D014516 | Ureteral Neoplasms |
C00001513
|
D001749 | Urinary Bladder Neoplasms |
C00001513
|